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Abstract.  The decrease in abundance  of a  subset of 
highly  conserved basic nuclear proteins  is established 
to correlate  with the loss of proliferative  potential  in 
association  with the process of terminal  differentiation 
in murine  mesenchymal  stem cells and human ker- 
atinocytes.  These proteins,  designated  P2Ps for 
proliferation  potential  proteins,  have apparent  molecu- 
lar masses of 30-40 kD,  are associated  with the 
30-40S  substructures  of nuclear  hnRNP complexes, 
and are recognized by antibodies  made against core 
proteins  of hnRNP  particles.  They also share  an epi- 
tope in common with heat shock protein-90  (hsp90) 
and are recognized by two mAbs against hsp90.  Two- 
dimensional  electrophoretic Western blots furthermore 
show that  p2ps make up a  subset of hnRNP  proteins. 
Cells that possess these proteins  express the potential 
to proliferate  whether or not they are traversing  the 
cell cycle. These  include rapidly growing cells,  rever- 
sibly growth-arrested  cells,  and nonterminally  differen- 
tiated cells.  In contrast,  cells that have irreversibly lost 
their proliferative potential,  such as terminally 
differentiated  cells,  show a  marked  reduction in the 
abundance  of pEpS as determined  by immunodetection 
on Western blots.  A  correlation,  therefore,  exists be- 
tween the presence of this  subset of nuclear  proteins 
and the proliferative potential  in two cell types.  These 
results raise the possibility that as a  subset of hnRNP 
proteins,  P2Ps may mediate posttranscriptional  control 
of the processing  of specific RNAs required  for cell 
proliferation. 
M 
AMMALIAN cell differentiation  is associated with 
complex molecular changes involving both the ac- 
tivation and repression of multiple genes (25, 26). 
One of the important  biological processes associated with 
differentiation is the irreversible loss of proliferative poten- 
tial that occurs during a specific terminal event in differentia- 
tion (23, 35). Many cell types including hematopoietic, mus- 
cle, and neural cells undergo terminal differentiation as do 
adipocytes and epithelial cells (8,  35, 41).  To better under- 
stand the phenomenon  of differentiation-associated  loss of 
proliferative potential, this process has been studied in mu- 
rine 3T3 T mesenchymal stem cells (23, 35, 36) and normal 
human keratinocytes (24, 41). In 3T3 T cells, both nontermi- 
nal and terminal  states of differentiation have been defined 
and the transition from the nonterminal to terminal state has 
been experimentally characterized (3, 9, 23, 34). Addition- 
ally, the biochemical changes specifically associated with the 
loss of proliferative potential during terminal differentiation 
have been clearly distinguished  from those resulting  from 
nonterminal  differentiation per se (36). 
The current research was initiated to study changes in the 
expression of a variety of antigens during the process of non- 
terminal and terminal differentiation in murine 3T3 T cells 
and normal human keratinocytes by Western blotting proce- 
dures.  These assays demonstrated  that the abundance of a 
group of 30-40-kD  proteins detected by monoclonal  anti- 
bodies  against  both  heterogeneous  ribonuclear  (hnRNP) ~ 
core proteins and heat shock protein-90 were selectively re- 
duced when cells lost their proliferative potential in associa- 
tion with terminal differentiation. In contrast, these proteins, 
designated  p2ps  for  proliferation  potential  proteins,  were 
present in relative abundance in cells that retained their abil- 
ity to grow. Additional biochemical studies support the con- 
clusion that p2ps represent a subset of hnRNP proteins that 
could serve a regulatory role in the processing of RNAs that 
are important in determining a cell's proliferative potential. 
Materials and Methods 
Cell Culture: Murine Mesenchymal Stem Cells 
The BALB/c 3T3 T mesenchymal stem cell line and its derivation have pre- 
1.  Abbreviations  used  in  this paper:  CEPH,  a  human plasma fraction; 
hnRNP, heterogeneous ribonuclear proteins; HE  human plasma; hsIO0, 
heat shock protein,  90  kD  molecular mass; p2p,  proliferation potential 
proteins. 
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were maintained in DME containing 10% heat-inactivated fetal bovine se- 
rum (FBS) at 37°C in a 5% CO2 atmosphere. 
To reversibly arrest the growth of 3T3 T mesenchymal stem cells due to 
serum deprivation, they were plated at a density of 4  ×  103 cells/era  2 in 
DME containing 10% FIBS and after 12-24 h the cells were washed with 
DME and refed DME containing 0.5% FBS and maintained therein for 3-5 d. 
3T3 T mesenchymal stem cells can also be induced to undergo differenti- 
ation into adipucytes via a process that involves three steps: (a) predifferenti- 
ation growth arrest; (b) nonterminal differentiation; and (c) terminal differ- 
entiation.  This  process occurs in  a  progressive manner during  6-10-d 
interval after low density, rapidly growing cells are cultured in heparinized 
DME containing 25 % human plasma (DME/HP) (35).  Predifferentiation 
growth arrest and nonterminal differentiation are also induced when cells 
are cultured in heparinized DME containing a human plasma fraction desig- 
nated CEPH (DME/CEPH) as described previously (35). That is, in this 
medium the terminal event in the differentiation process is repressed (34). 
The kinetics of  this process are dependent  on the substrate used to culture 
the cells (35),  but in general, within 3 d  after addition of DME/HP or 
DME/CEPH,  most cells undergo growth arrest at the predifferentiation 
state. Soon thereafter, most of such cells become nonterminally differen- 
tiated and thereafter when cultured in DME/HP, the vast majority of  the cell 
population develops into terminally differentiated adipocytes. By use of 
these media and these special tissue culture manipulations, it is possible to 
obtain highly enriched populations of cells at each of the three states de- 
scribed above (35). These procedures were therefore used to prepare cell 
populations for the current studies. 
It is important to emphasize that both nonterminally and terminally dif- 
ferentiated cells are adipocytes that are characterized by their expression of 
intracytoplasmic lipid droplets detected by phase contrast microscopy. This 
morphological criterion has been shown to correlate very well with enzy- 
matic assays of  adipocyto differentiation (9). The most significant difference 
between nonterminally and terminally differentiated adipocytes is the ability 
of the former to undergo DNA synthesis and clonal growth after restimula- 
tion with 30% FBS plus 50 t,g/ml insulin in DME, whereas the latter are 
irreversibly growth arrested and are therefore refractory to growth factor 
restimulation. 
Cell Culture: Normal~Human Keratinocytes 
The procedure for preparing primary and secondary cultures of normal hu- 
man keratinocytes was the same as that previously described in detail (41). 
Such cells are cultured in serum-free medium designated complete MCDB 
153 prepared in our laboratory according to published procedures (2, 41). 
This medium also contains: 0.1 mM ethanolamine, 0.1 mM phosphoetha- 
nolamine, 5  ×  10  -7 M  hydrocortisone, 5 #g/ml insulin,  10 ng/ml EGF, 
and 140 ~g/ml bovine pituitary extract. Complete MCDB 153, containing 
0.1 mM calcium, was used to prepare rapidly growing cultures of undiffer- 
entiated keratinocytes which do not express involucrin nor form morpholog- 
ical foci of stratified "crowns," which are excellent keratinocyte differentia- 
tion  markers  (31).  To  induce terminal differentiation of normal  human 
keratinocytes, rapidly growing cells at a density of '~,5-8  ×  103 cells/cm  2 
were refed MCDB 153 containing all described additives and 2 mM calcium 
and were thereafter allowed to terminally differentiate at a higher cell den- 
sity of ,~2  ×  104 cells/cm  2. In some studies, EGF and insulin were also 
removed from the medium, and/or 8 mM ethionine (Aldrich Chemical Co., 
Milwaukee, WI) was added to the medium to promote even more efficient 
keratinocyte growth arrest and differentiation (40). This was typically per- 
formed in lower density cultures. After incubation under these conditions 
for 7-12 d, maximum differentiation of 45-75 % of the cells could typically 
be detected by use of  a variety of  keratinocyte differentiation markers includ- 
ing morphological, histochemical, and immunological techniques that have 
been previously described in detail (39-41). 
mAbs 
A series of six mAbs were used in these studies. Antibodies iD2 and fA12 
are mouse lgM mAbs prepared against hnRNP core proteins (11). Antibod- 
ies AC88,  4F3, 7DII, and D7a are mouse IgG mAbs against hsp90; 4F3, 
7DII, and EffA were prepared against chicken hsgO0 and AC88 against an 
hsp90 homotogue of the water mold Achlya ambisexualis (30). These anti- 
bodies were used for Western blotting at 1-10 #g/ml. 
SDS-PAGE and Western Blotting 
Samples for one-dimensional electrophoresis which were dissolved in the 
SDS sample buffer, were boiled for 2 min, and then resolved by electropho- 
resis on 7.5% acrylamide gels as described (10). Western blotting and anti- 
body probing procedures were performed as described (12, 28). Briefly, af- 
ter the transfer of  proteins onto nitrocellulose sheets, incubation was carried 
out for 1 hour at room temperature in the Western buffer (20 mM Tris-HCl, 
pH 7.4,  150 mM NaCI, 0.5% [vol/vol] Tween 20, and 0.1% [wt/vol] BSA) 
to block nonspecific binding of antibody to nitrocellulose. Probing was per- 
formed overnight at 4°C in the Western buffer containing 1-10 #g/ml of the 
mAbs. Nitrocellulose sheets were subsequently washed with Western buffer 
and probed for 2 h at room temperature using a second antibody, alkaline 
phosphatase-conjugated goat anti-mouse tg  antibody (Fischer Biotech, 
Orangeburg, NY).  After extensive washing with Western buffer, the im- 
munocomplexes on the nitrocellulose were visualized with 330/~g/ml nitro- 
blue tetrazolium and 166 t~g/ml 5-bromo-4-chloro-3-indolyl phosphate in 
100 mM Tris-HCl,  100 mM NaCI, pH 9.5,  containing 50 mM MgCI2.  In 
some experiments a radioactive secondary antibody was used to detect the 
immunocomplexes  (12).  For  total  protein  visualization,  nitrocellulose 
sheets were stained with 0.1% (vol/vol) India ink in PBS with 0.3% Tween 
20 for 4-6 h. 
Two-dimensional NEPHGE electrophoresis was performed by the O'Far- 
rell method (18).  The NEPHGE lysis buffer contained 9.5  M  urea, 2% 
wt/vol Triton XI00, 1.6% wt/vol ampholine 5-7, and 0.4% wt/vol ampholine 
3.5-10 (Servalyte; Serva Fine Biochemicals, Garden City Park,  NY) and 
5% vol/vol 2-mercaptoethanol. 
Proliferation Assays 
To evaluate the proliferative potential of 3T3 T cells and human keratino- 
cytes, two standard assays were used and both have been previously de- 
scribed in detail (9, 35). First, the ability of cells to incorporate [3H]thymi- 
dine into DNA during the S phase of the cell cycle was evaluated using 
autoradiographic methods (6, 9). Second, the clonogenic potential of cells 
was assayed wherein ,x,500 cells were plated onto dishes in optimum growth 
medium, i.e., DME/30% FCS plus 50 #g/ml insulin or complete MCDB 
153, respectively, and cultured therein for 10-14 d after which, the percent- 
age of cells that formed colonies greater than four to eight cells was deter- 
mined (35). 
Preparation of  Cell Extracts 
Biochemical analyses were performed on total cell homogenates and on 
specific cell fractions. To prepare total  homogenates, cells were scraped 
from dishes with a rubber policeman and washed twice with PBS, pH 7.4. 
Cells were lysed by addition of 50 #1 of the SDS sample buffer (125 mM 
Tris-HCl, pH 6.8, 5% [vol/vol] 2-mercaptoethanol, 1% [wt/vol] SDS, 10% 
[vol/vol] glycerol, and 0.025 % [wt/vol] hromophenol blue). Samples were 
mixed on a vortex apparatus and stored at  -70°C until used for gel elec- 
trophoresis. 
To prepare cytosol and nuclear fractions, a modification of a nuclear iso- 
lation method was used (12). Briefly, cells were harvested by scraping with 
a rubber policeman and were washed twice with PBS, pH 7.4.  Cells were 
lysed by addition of a hypotonic solution containing 10 mM Tris-HCI, pH 
7.4,  3 mM MgCI2,  15 mM KCI, and 0.75%  Triton X-100 (TKM buffer). 
Nuclei were sedimented over a layer of 1 M  sucrose in TKM buffer.  The 
remaining supernatant was mixed with an equal volume of2x SDS sample 
buffer (see above) and used as the cytosolic fraction. The nuclear pellet was 
extracted with 0.35 M NaCI and 50 mM Tris, pH 7.4,  and this extraction 
was also dissolved in 2× SDS sample buffer. Additional methods described 
below were used to isolate more pure nuclear preparations from various tis- 
sues and specimens. 
Preparation of  Nuclei from Cultured Cells 
Intact cells were harvested and washed several times in ice cold solution of 
PBS and collected by centrifugation. The cell pellet was then lysed by addi- 
tion of TKM containing 0.75% Triton Xd00 and the lysate was centrifuged 
at 15,000 rpm for 10 min in a microfuge to sediment  the nuclei. The nuclear 
pellet was washed once in TKM without Triton X-100 and directly lysed by 
addition of  either SDS sample buffer (125 mM "Iris, 1% SDS, 0.025 % brom- 
phenol  blue,  10%  glycerol,  and  2.5%  mercaptoethanol  [pH  6.8])  and 
boiled, or the nuclear pellet was lysed in the two-dimensional nonequili- 
brium pH gradient gel electrophoresis (NEPGHE) sample buffer (described 
below) and stored at  -70°C for subsequent analysis. 
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Biological States and the Relative Abundance of P2Ps 
Growth  Differentiation  Proliferative  Relative 
Cell type  Biological state  characteristic  characteristic  potential  p2p abundance 
3T3 T  Rapid growth state  Growing  Undifferentiated  +  + 
Serum deficiency state  Reversibly arrested  Undifferentiated  +  + 
Nonterminal differentiation  Reversibly arrested  Adipocyte  +  + 
Terminal differentiation  Irreversibly arrested  Adipocyte  -  - 
CSV3-1*  Rapid growth state  Growing  Undifferentiated  +  + 
Nonterminal differentiation  Reversibly arrested  Adipocyte  +  + 
* CSV3-1 cells do not efficiently  undergo the terminal step in differentiation. 
Isolation of  hnRNP on Sucrose Gradients 
The 30--40S subcomplexes of hnRNP were extracted and isolated by the 
method of Wilk et al. (37, 38). Typically, 1 X  10  7 cells were washed twice 
with PBS and resuspended in 10 mM Tris,  10 mM NaCI, and 1.5 mM 
MgCI2, pH 7.0, at IlY  i cells/ml. The nonionic detergent NP40 was added 
to ceils to a final concentration of 0.5%. After 10 min on ice, the ceils were 
homogenized in a type B Dounce homogenizer. The homogenate was cen- 
trifuged for l0 min at 800 g and the supernatant removed. The pellet was 
washed sequentially with ice-cold 10 mM Tris, 100 mM NaCI, and 1.5 mM 
MgCI (STM, pH 7.0), and then with the same buffer at pH 8.0. The cells 
were resuspended in STM pH 8.0 at 3-5 x  106 cells/ml and stirred slowly 
for 30 min at 22°C. Insoluble material was sedimented by centrifugation at 
800 g for 10 min and discarded. This procedure was then repeated. After 
sedimentation of insoluble material, the supernatants were pooled and ap- 
plied to a  15-30% sucrose gradient in the extraction buffer. The gradiem 
was centrifuged for 16 h at 90,000 g and then fractionated into 1-ml  aliquots. 
Subsequent to determination of OD values by spectrophotometry (A260) in 
each sample, the total protein in each sample was precipitated by chloro- 
form/methanol (33). Precipitated proteins in each sample were suspended 
in SDS sample buffer, boiled for 2 min and analyzed by PAGE  and Western 
blotting. 
For the identification of antigens associated with larger and more native 
hnRNP complexes, cell extracts were prepared in the presence of ribonu- 
clease inhibitor. HeLa cell nuclei were isolated according to Martin and 
McCarthy (17) and washed twice with STM (pH 7.0) containing 100 U/ml 
placental ribonuclease inhibitor (Amersham Corp., Arlington Heights, IL). 
The washed nuclei were sonicated in 4 pellet volumes of STM pH 7.0 with 
RNase inhibitor and the debris was removed by centrifugation. The extract 
was resolved by sedimentation for 16 h at 50,000 g on a 35-ml 15--40% su- 
crose density gradient containing STM pH 7.0 (12). Absorbance at 254 nm 
was monitored using an UV analyzer and 3-ml aliquots were collected for 
the analysis of proteins by immunobloaing. 
Results 
The data  in this manuscript will show  that the abundance 
of a  group  of basic  nuclear proteins,  designated  p2ps  for 
proliferation  potential  proteins,  selectively  and  markedly 
decreases only in cells that have irreversibly lost their poten- 
tial  to  proliferate  in association  with  terminal differentia- 
tion. l~Ps were detected by Western blotting with antibodies 
against hnRNP core proteins or hspg0 and Table I  summa- 
rizes the relationship between proliferation potential and the 
abundance of trips. 
To evaluate potential changes in the abundance of different 
antigens during the process  of differentiation, a  variety of 
mAbs, including those against hnRNP proteins (11) and hspg0 
were used.  One designated AC88 recognizes an epitope in 
hspg0 that is well conserved among eukaryotes (30).  West- 
em blots of total cellular extracts of undifferentiated 3T3 T 
Figure 1. Localization of p2ps 
to the nucleus in 3T3 T  cells. 
Rapidly growing 3T3 T  cells 
were either prepared  as total 
cell lysates by homogenization 
in SDS sample buffer or frac- 
tionated into cytosolic and nu- 
clear preparations as described 
in  Materials  and  Methods. 
Samples were electrophoresed 
on  10%  SDS-polyacrylamide 
gels and transferred to  nitro- 
cellulose by Western blotting. 
P2Ps  and hsp90 were  identi- 
fied by probing the nitrocellu- 
lose with antibody AC88 and 
subsequent  visualization  of 
the protein bands by use of an 
alkaline phosphatase conjugated rabbit antimouse immunoglobu- 
lin. Each lane represents an approximately equal number of calls. 
Cytosol and nuclear fractions were derived from the same sample 
of cells. Protein molecular mass standards indicated by arrows on 
the left of the figure are phosphorylase b, 97 kD; BSA, 68 kD; oval- 
bumin, 43 kD; lactate dehydrogenase, 36 kD; and carbonic anhy- 
drase, 29 kD. 
Figure 2.  A comparison of the anti- 
gens recognized by antibodies AC88 
and fA12 in whole 3"1'3  T cell extracts 
shows  that  AC88  recognizes  both 
P2Ps and hsp90 but that fA12 only 
recognizes P2Ps. 
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these cells.  The results showed that AC88 not only recog- 
nized hsp90 but,  in addition,  a  group of distinct proteins 
designated peps with 30-40-kD apparent molecular masses. 
Fig.  1 shows that PEPs have a nuclear localization in 3T3 
T cells, in contrast to hsp90, which is primarily localized to 
the cytoplasm. Detection of pEpS is specifically dependent 
on the presence of AC88 or fA12 antibodies since omission 
of these antibodies resulted in the failure to detect P2Ps by 
Western blotting (data not shown). In addition, presaturation 
of antibody AC88 with purified hsp90 eliminated the West- 
ern blot signal  for both hsp90 and for the 30-40-kD PEP 
proteins. 
To determine if other anti-hsp90 antibodies could recog- 
nize PEPs, three additional  hsp90  mAbs,  designated 4F3, 
D7a, and 7Dll, were incubated with Western blots of cellular 
extracts  from the  chick oviduct because  these  antibodies 
are specific for avian hsp90 (30). Preliminary experiments 
showed that the results in Fig.  1 could be duplicated using 
chicken tissue. Similar results have been observed with the 
water mold Achlya,  rabbit tissues, and human tissues (data 
not shown). These antigens therefore appear to be very high- 
ly conserved.  In  chickens,  all  four hsp90  antibodies  rec- 
ognized hsp90,  but P2Ps were only detected by antibodies 
AC88 and 4F3 (see Materials and Methods) (30). The latter 
antibody gave a relatively weak, but reproducible reaction. 
The absence of reactivity with PEPs using avian hsp90-spe- 
cific mAbs D7a and 7Dll demonstrates specificity of  4F3 and 
AC88  for PEP antigens  and  rules  out the possibility of a 
general affinity for nonspecific antibodies to interact with 
P2Ps. Based on these results it was concluded that PEPs and 
hsp90 share at least one epitope in common. 
The possibility that p2p antigens  might result  from the 
artifactual proteolysis of hsp90 was explored even though 
several biochemical characteristics of p2ps and hsp90 argue 
against this possibility. For example, hspg0 is an acidic cyto- 
solic protein with an isoelectric point reported to be between 
4.5 and 5.5  (32).  In contrast, PEPs are basic nuclear pro- 
teins with pIs of ~9.0 (see Fig. 4). A series of experiments 
using protease inhibitors showed no effect on PEP or hsp90 
abundance suggesting that PEPs are not artifactual in vitro 
proteolytic products of hsp90.  More important, PEPs were 
also recognized by the fA12 mAb prepared against core pro- 
teins of hnRNP particles and this antibody does not recog- 
nize hsp90 epitopes. Fig. 2 demonstrates this finding. 
The testing of antibodies against hnRNP proteins was sug- 
gested by preliminary efforts to fractionate PEPs. The PEPs 
appeared to be associated with larger complexes and espe- 
Figure 3. (A) p2ps are found within the 30-40S peak of nuclear extracts on sucrose density gradients. Nuclear extracts from 3T3 T cells 
were centrifuged through a 15-30% sucrose gradient as described in the Materials and Methods. Fractions collected across the gradient 
were resolved by one-dimensional gel electrophoresis on 10% polyacrylamide gels and Western blotted with AC88 antibody. The profile 
of the absorbance at 260 nm is shown; inset illustrates selected fractions from the Western blot detection of p2ps. (B) p2ps cosediment 
with known core proteins in large hnRNP complexes prepared in the presence of placental RNase inhibitor. HeLa cell nuclear extracts 
were resolved by centrifugation on 15-40%  sucrose gradients. Complexes detected on this gradient range from the 30S subcomplex to 
structures of '~ 200S. The proteins contained in gradient fractions were electrophoresed, Western blotted, and probed with mAbs using 
the radioactive second antibody method. The hnRNP core proteins and the AC88 antigen cosediment precisely throughout the gradient. 
Note that the fAl2 antibody also reacts with an hnRNP protein of 57 kD, not recognized by AC88. 
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within nuclei (5, 13). Based on these observations, the possi- 
bility was explored that tnPs might be related or identical 
to protein moieties of hnRNP complexes (13, 15, 16). When 
nuclei are extracted without extensive precautions to prevent 
ribonuclease action, hnRNP complexes are commonly iso- 
lated as relatively homogeneous 30-40S subcomplexes. We 
therefore examined the distribution of p2ps in conventional 
extracts of hnRNPs resolved by sucrose gradient sedimenta- 
tion (37, 38).  Fractions collected after centrifugation were 
analyzed for the presence of P2Ps by Western blotting using 
AC88 antibody. The data show the cosedimentation of the 
InPs with the optical density peak of the 30-40s  hnRNP 
subeomplex (Fig. 3 A); there are no significant amounts of 
the 30--40-kD  antigen at the top or bottom of the gradient. 
Because these preliminary findings suggested an associa- 
tion of triPs with hnRNP complexes,  we sought to deter- 
mine if the proteins were also present in large, presumably 
more native complexes. A nuclear extract from HeLa cells 
prepared in the presence of placental ribonuclease inhibitor 
was resolved by sucrose gradient sedimentation. Complexes 
of 30-200S that contained hnRNP core proteins recognized 
by the rnAbs iD2 and fA12 were obtained (Fig. 3 B). The 
30-40-kD  antigens detected by  AC88  cosedimented pre- 
cisely with the bona fide hnRNP polypeptides. Extremely 
mild RNase treatment of extract converted the bulk of all 
three antigens to a form that sedimented at 30S (results not 
shown). Thus, the p2p proteins appear to be constituents of 
native hnRNP complexes, and behave as if they were novel 
members of the basic core protein family. 
l~Ps Represent Novel Components of  hnRNP 
To further characterize the relationship between hnRNP par- 
ticles and p2ps,  the properties of p2p antigens were com- 
pared with those of previously described major core poly- 
peptides of hnRNP complexes which fall into three distinct 
size groups termed A, B, and C (13). Based on their molecu- 
lar size, p2ps could represent group A or group B hnRNP 
proteins because these polypeptides are basic in charge and 
range in size between 35 and 40 kD. However, the A, B, and 
C groups each contain multiple proteins and the total number 
of hnRNP proteins has been estimated to be >20 (5, 12, 37). 
To determine whether P2Ps are similar or identical to such 
hnRNP proteins, we compared, by two-dimensional NEPHGE 
gel electrophoresis and Western blotting, the pattern of P2Ps 
with those of previously described hnRNP proteins.  This 
analysis was performed on HeLa cell extracts to allow better 
comparisons with previous reports on HeLa hnRNP proteins 
(12, 37). Fig. 4 shows that antibody iD2 indeed recognizes 
several major hnRNP proteins in the A  and B groups and 
presents the typical arrowhead pattern (12). In contrast, fA12 
recognizes a group of hnRNP proteins that are mostly differ- 
ent from those recognized by iD2, although there are possi- 
ble overlapping spots recognized by both antibodies.  The 
pattern of staining with AC88 closely resembles that ob- 
tained with fA12  for p2p  associated hnRNPs.  To identify 
regions of coincidence,  combinations of these  antibodies 
were used next. Probing with AC88 and fA12 in combination 
consistently demonstrated that AC88 epitopes are a subset of 
protein spots recognized by fA12 alone. Although a  small 
number of iD2-recognized protein spots are coincident with 
those recognized by fA12, iD2, and AC88, epitopes do not 
appear to exhibit detectable overlaps. The AC88 antigens ap- 
pear to be among the C1, B1, and B2 hnRNP proteins de- 
scribed by Wilk et al.  (37) or the B1  and B2 proteins de- 
scribed by Dreyfuss et al.  (5). 
bTgure 4. Comparison  of P2Ps and 
known hnRNP proteins on two- 
dimensional NEPHGE gels. To 
determine whether p2ps are iden- 
tical or similar to the previously 
described  major  core  polypep- 
tides of hnRNP particles, equal 
quantities of isolated HeLa cell 
nuclei were lysed in NEPHGE ly- 
sis buffer and electrophoresed on 
two-dimensional NEPHGE gels. 
After Western  blotting, one of the 
three antibodies or a combination 
of antibodies was used to identify 
antigens. Each  panel  illustrates 
the antigens recognized on West- 
ern blots by the antibody desig- 
nated in each case. The relation- 
ship of  these antigens is indicated 
by a schematic derived by testing 
combinations of the  three  anti- 
bodies, o, antigens detectable by 
fal2;  e, antigens recognized by 
iD2  alone;  and  o,  iD2,  fAl2 
cross-reactive antigens. The ar- 
rows indicate the p2p antigens. 
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31"3 T Cells 
Mesenchymal stem cells in culture regulate their prolifera- 
tion and differentiation in a  coordinated fashion.  A  model 
that describes  linkages  in  the  control  of proliferation and 
differentiation in these cells has been described by Scott et 
al.  (22, 23).  Those data show that 3T3 T  cells can develop 
into either nonterminally or terminally differentiated adipo- 
cytes. Both types of adipocytes represent mature fat cells on 
the basis of morphology; however, nonterminal adipocytes 
retain their proliferative potential, whereas terminal adipo- 
cytes do  not.  That is,  terminally differentiated adipocytes 
cannot be stimulated to proliferate by any known growth fac- 
tors or mitogens (35).  Table I  summarizes these important 
biological characteristics and stresses that only terminally 
differentiated 3T3 T adipocytes lose their proliferative poten- 
tial and show a  marked decrease in p2p abundance. 
The existence of separate states of nonterminal and termi- 
nal  differentiation  makes  it  possible  to  distinguish  events 
related to differentiation per se from those that are selectively 
associated with the irreversible loss of proliferative potential 
which occurs only with terminal differentiation. Therefore, 
to determine  if changes  in  the  abundance  of P2Ps  occurs 
only with terminal differentiation, equal numbers of 3T3 T 
cells at different biological states were isolated and cells were 
processed for Western blotting; and P2Ps were identified by 
use of the AC88 antibody. Similar results were obtained with 
the  fA12  antibody  (data  not  shown).  The results  (Fig.  5) 
show a  strong correlation between the loss of proliferative 
potential and the decreased abundance of P2Ps. It is impor- 
tant to stress that no major change in hsp90 abundance which 
served as an internal control was detected during this inter- 
val. Fig. 5 B also shows that during the process of differen- 
tiation-induced  irreversible  loss  of proliferative potential, 
only slight changes occur in the majority of core hnRNP pro- 
t~ins that are recognized by the iD2 antibody probe. In this 
regard, maximum nonterminal adipocyte differentiation oc- 
curs between days 5  and 7,  when 'x,30-80% of cells were 
differentiated but retained their proliferative potential.  Fig. 
5 A shows no major change in P2Ps during this interval. In 
contrast, from days 7 to 12, the relative percentage of termi- 
nally  vs.  nonterminally  differentiated  cells  progressively 
increases  concurrent  with  loss  of proliferative  potential. 
Figure 5. (A) Kinetics of the 
reduction in steady-state levels 
of  p2ps  associated  with  the 
loss of proliferative  potential 
that occurs during the terminal 
differentiation of 3T3 T cells. 
Low-density, rapidly growing 
3T3 T  cells  were  induced to 
undergo  terminal  differentia- 
tion in heparinized DME con- 
taining  25%  human  plasma 
as described  in Materials and 
Methods.  Duplicates of sam- 
ples  on  the  days  designated 
were  removed and  analyzed. 
One sample was used to iden- 
tify the steady state levels of 
p2ps  and  hsp90  by  probing 
Western blots of total cellular 
proteins  with mAb ACSK In 
these assays, equal numbers of 
cells were evaluated. Relative 
optical density of P2Ps in each 
sample was subsequently deter- 
mined by densitometric  scan- 
ning of Western blots. A dupli- 
cate sample was also used to 
determine the proliferative po- 
tential of cells at different dif- 
ferentiation sta~. More specif- 
ically, the proliferative  response 
of  differentiating  cells  was 
determined  by treating  them 
with high growth factor con- 
centrations and measuring [3H]thymidine incorporation into DNA as described in Materials and Methods.  (B) Comparison between iD2 
and AC88 epitopes detected during the differentiation of3T3 T cells in vitro. Equal numbers of cells on specific days during differentiation 
were collected and lysed in the SDS lysis buffer. Each sample was then divided in half and electrophoresed on 12% polyacrylamide gels, 
Western blotted, and probed with either iD2 or AC88 separated. (A) Cells before induction of differentiation; (B-E) cells on different days 
after differentiation induction;  (B) day 2; (C) day 5; (D) day 8; and (E) day 12.  During the differentiation response cells first become 
nonterminally differentiated at approximately day 5. Then some cells begin to undergo the terminal event in differentiation between days 
6-10. Finally, by approximately day 12, most of the adipocytes have lost their proliferative potential and are therefore terminally differen- 
tiated. 
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loss of proliferative potential that occurs in association with termi- 
thai differentiation in nontransformed 3T3 T cells. In contrast, in a 
SV40-transformed 3T3 T clone designated CSV3-1 that can differ- 
entiate but not terminally, no change in p2p levels occurs. A shows 
that 3T3 T and CSV3-1 cells differentiate equally well. However, 
only 3T3 T cells lose their ability to be restimulated to grow as the 
differentiation process proceeds, i.e., days  0, 7, and 12. These data 
were derived  by autorediographic analysis of [3H]thymidine in- 
corporation and are presented as percent labeled nuclei. Data on 
CSV3-1 are on the left bar graphs with parallel lines; 3T3 T data 
on the right bar graphs with diagonal lines. B compares the relative 
abundance of P2Ps in rapidly growing (RG, day 0) and differen- 
tiated (DF, day 12) 3T3 T and CSV3-1 cells by use of Western blot- 
ting using the  AC88 antibody and shows that the abundance of 
P2Ps only decreases in adipocytes that irreversibly lose their pro- 
liferative potential. 
During this  latter interval, the level of p2ps progressively 
decreases even though the percentage of adipocytes remains 
constant. 
Additional assays were performed to further evaluate wheth- 
er the decrease in the abundance of P2Ps is directly associ- 
ated with the terminal event in differentiation or differen- 
tiation per se.  For this purpose, we evaluated whether the 
abundance  of l~Ps  is  reduced during differentiation of a 
unique clone of SV40-transformed 3T3 T  stem cells, desig- 
nated CSV3-1 (21). This clone retains the ability to differenti- 
ate to an extent comparable to parental 3T3 T cells, but can- 
not undergo extensive terminal differentiation (Table I). Fig. 
6  A shows that both 3T3 T  and CSV3-1  cells differentiate 
equally well but that only 3T3 T adipocytes undergo terminal 
differentiation. Furthermore, as adipocyte differentiation oc- 
curs, 3T3 T cells lose their ability to be stimulated to grow 
whereas CSV3-1  adipocytes do not lose their proliferative 
potential.  Fig.  6  B  shows Western blot analysis of l~Ps in 
rapidly growing and differentiated 3T3 T and CSV3-1 cells. 
In contrast to normal 3T3 T stem cells, which show a marked 
decrease in  p2p  levels during  terminal  differentiation, no 
detectable change in the abundance of l~Ps in CSV3-1 cells 
is observed, even when such cells are cultured for extended 
intervals in medium that promotes terminal differentiation in 
parental 3T3 T  cells. Therefore, it appears that if cells fail 
to undergo terminal differentiation, the decrease in abun- 
dance of P2Ps does not occur. These data further support 
the conclusion that reduction in abundance of l~Ps is not 
associated with differentiation per se but rather with the ter- 
minal event in differentiation. 
Reversible Growth Arrest in 3T3 T Stem Cells by Serum 
Deprivation Does Not Modulate pzp Levels 
The above data demonstrate a strong correlation between the 
irreversible loss of  proliferative potential in terminally differ- 
entiated cells and the marked decrease in the abundance of 
p2ps. To further substantiate this observation, we examined 
the steady-state levels of P2Ps at a reversible growth arrested 
state induced by serum deficiency in 3T3 T  cells (Table I). 
Such reversibly growth-arrested cells retain their prolifera- 
tive potential because they can be subsequently restimulated 
to reinitiate cell cycle progression and cell division. We also 
evaluated whether the abundance of P2Ps changed after re- 
versibly growth-arrested  cells  are  stimulated  to  reinitiate 
proliferation. For this purpose, the growth of 3T3 T  stem 
cells was arrested by culture in serum-depleted medium and 
the abundance of P2Ps was assayed by immunodetection of 
Western blots.  Similarly, after growth was arrested which 
was determined by a markedly decreased [3H]thymidine in- 
corporation into DNA and by the absence of increases in cell 
density, specimens were sequentially isolated after growth 
restimulation with medium containing  10 or 30%  FBS to 
evaluate tnP levels. Fig. 7 shows that no significant change 
in the abundance of P2Ps occurred during reversible growth 
arrest nor during the reinitiation of  proliferation in quiescent 
cells. These data demonstrate that I~P levels are not affect- 
ed by reversible growth arrest nor by serum-induced growth 
stimulation in 3T3 T stem cells. More importantly, these data 
suggest that unlike serum/growth factor responsive proteins 
(1,  14,  20), the decline in triP levels is a specific event oc- 
curring only in conjunction with loss of proliferative poten- 
tial during terminal differentiation and not with reversible 
quiescence. 
Modulation of P2Ps during Differentiation of Normal 
Human Keratinocytes 
Preliminary results  suggested that p2ps  are evolutionarily 
well conserved in a wide range of eukaryotic species from 
filamentous fungi to human cells (data not shown).  It was 
therefore possible to evaluate whether or not the characteris- 
tics of l~Ps change during the process of terminal differen- 
tiation of other cell types. For this purpose, the steady-state 
levels of p2ps were analyzed during the terminal differentia- 
tion of normal human keratinocytes. The development of 
serum-free media for the culture of normal human skin epi- 
thelial cells has facilitated the study of the biological mecha- 
nisms that regulate keratinocyte proliferation and differentia- 
tion (2). Wille et al. have established that, as in 3T3 T stem 
cells, the proliferation and differentiation of human keratino- 
cytes are integrally regulated (41). In contrast to 3T3 T cells, 
however, the process of  differentiation in normal human ker- 
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tion does not alter p2p levels. Duplicate samples of equal numbers 
of 3"1"3 T cells were cultured in medium containing 0.5% FBS to 
induce reversible growth arrest. On each day thereafter, one sample 
of  each duplicate set of specimens was analyzed by Western blotting 
of total cellular  proteins.  P2Ps were  identified by probing  with 
mAb AC88. The other sample was used for determination of per- 
centage of cells undergoing DNA synthesis by measurement of 
[3H]thymidine incorporation by autoradiography. After growth ar- 
rest occurred by day 5, cells were stimulated to grow by the addition 
of 30% FBS and were subsequently analyzed on days 6 and 7. 
atinocytes is not as highly synchronized. For example, when 
keratinocytes are placed in differentiation-promoting medi- 
um, different members of the population growth arrest and 
differentiate with distinct kinetics. Some differentiate within 
2-4 d,  whereas others may require 6-10 d to differentiate. 
Indeed, some normal human keratinocytes never fully dif- 
ferentiate in vitro even though they can all eventually lose 
their proliferative potential. Nonetheless, a good correlation 
does exist between the expression of differentiation markers 
and loss of colony-forming efficiency in normal human ker- 
atinocytes (36). 
Cultures of normal human keratinocytes were, therefore, 
induced to undergo terminal differentiation in vitro, during 
which time cell samples were examined for their differentia- 
tion characteristics and for loss of proliferative potential by 
assaying their clonogenic potential, i.e., the ability of single 
cells to form colonies. Samples containing equal numbers of 
cells were also evaluated by Western blot analysis to assay 
P~P levels. Total cellular protein from each sample was aria- 
lyzed by SDS-PAGE, blotted onto nitrocellulose, and probed 
with AC88 antibody. Fig. 8 shows that in normal human ker- 
atinocytes, the abundance of P~P is also selectively reduced 
when ceils irreversibly lose their proliferative potential in as- 
sociation with terminal differentiation.  Additional data not 
plotted show the extent of keratinocyte differentiation, as de- 
termined  by  involucrin  expression and  cell  stratification, 
which are excellent markers of keratinocyte differentiation: 
day 0, 0%; day 3,  15%; day 6, 30%; and day 9, 45%. This 
demonstrates that in two mammalian species and two sepa- 
rate cell types, downregulation of triP levels correlates close- 
ly with the loss of proliferative potential associated with ter- 
minal differentiation. 
Discussion 
Delineation of the  mechanisms  that  regulate proliferation 
and differentiation of mammalian cells is essential to under- 
stand a variety of  health-related problems, including carcino- 
genesis.  One very important question concerns how cells 
regulate the process of terminal differentiation wherein they 
irreversibly lose  their  proliferative potential.  In  previous 
studies, the biological events in the terminal differentiation 
of 3T3 T  mesenchymal stem cells (23,  34-36) and normal 
human keratinocytes (39-41) were established. In these stud- 
ies, both cell systems were used to evaluate the steady-state 
levels of a  group of distinct  nuclear proteins,  designated 
IrPs for proliferation potential proteins. These antigens were 
identified by virtue of  thei:r strong cross reactivity with mAbs 
to hnRNP proteins that share an epitope with hsp90. 
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Figure 8. Reduction in the steady-state level of P2Ps during the ter- 
minal differentiation of normal human keratinocytes. Normal dip- 
loid human keratinocytes were induced to undergo terminal dif- 
ferentiation by culture  in serum-free medium containing 2  mM 
Ca  2+. Samples of keratinocytes undergoing terminal differentiation 
were then periodically collected and analyzed for P:P levels by 
Western blotting of total cellular proteins using antibody AC88. 
Duplicate samples of keratinocytes were also used to assay the ex- 
tent of differentiation and cellular  proliferation potential by the 
colony-forming efficiency method described. 
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of proliferative potential during terminal differentiation in 
two independent mammalian cell types. To establish that this 
decrease in the abundance of PEPs occurs specifically dur- 
ing the terminal event of differentiation a temporal compari- 
son was made between the loss of PEPs and the loss of re- 
sponsiveness to mitogenic stimulation during differentiation 
of 3T3 T cells. The results demonstrate a strong correlation 
between decreased steady-state levels of pEpS and the per- 
centage of irreversibly terminally differentiated cells. Sec- 
ond, the abundance of peps does not change when murine 
3T3 T stem ceils were induced to reversibly growth arrest by 
serum deprivation nor was there any significant  change in the 
level of these proteins when such growth-arrested cells were 
restimulated to proliferate. Third, it was shown that in CSV3- 
1 cells, an SV40-transformed cell line that undergoes nonter- 
minal differentiation but not terminal differentiation, changes 
in the abundance of PEPs do not occur. This strongly sug- 
gests that changes in pep levels are not a  consequence of 
differentiation per se, but rather suggests that these changes 
are specifically associated with the irreversible loss of pro- 
liferative potential during terminal differentiation. These ob- 
servations are most significant because very few if any spe- 
cific changes in other nuclear proteins have been reported in 
association with the terminal event in differentiation (25, 27). 
Another important observation is  that pEpS represent a 
subset of hnRNP proteins. This observation raises the possi- 
bility that posttranscriptional regulation of gene expression 
via changes in specific hnRNP components may play a sig- 
nificant role in the control of a cell's proliferative potential. 
HnRNP proteins have long been presumed to mediate the 
correct packaging of hnRNA within the nucleus much in the 
same way as nucleosomal proteins package DNA into chro- 
matin (16). Recent evidence further suggests that hnRNP- 
associated proteins  may be  essential  components of pre- 
mRNA splicing and processing machineries in the nucleus. 
For example, it has been shown that the class C hnRNP pro- 
teins are involved in splicing (3, 5). The abundance of other 
core polypeptides of hnRNP proteins, i.e., the complement 
of groups A and B, has also been demonstrated to change 
during the cell cycle (12). Finally, electron microscopic ob- 
servations of chromosome preparations suggest that specific 
pre-mRNAs  very rapidly become associated with snRNP 
and hnRNP protein particles (7,  19).  Recent findings that 
some hnRNP proteins exhibit RNA binding specificities (29) 
support the possibility that different  pre-mRNAs may require 
specific combinations of hnRNP and snRNP proteins  for 
their  correct  splicing,  processing,  and nucleocytoplasmic 
transport. Data derived from these studies raise the interest- 
ing possibility that certain subsets of hnRNA binding pro- 
teins, i.e., those containing l~Ps, might be essential for the 
maturation of specific proliferation-associated pre-mRNAs. 
The types of mRNA that may be dependent on pEpS for 
their processing, maturation, and nucleocytoplasmic trans- 
port need to be further investigated by the use of more specific 
mAb probes with which it would be possible to immunopre- 
cipitate and isolate hnRNA-protein complexes. Development 
of cDNA clones and subsequent derivation of mAbs to syn- 
thetic peptides should greatly facilitate this type of analysis. 
Because triPs share at least one epitope in common with 
eukaryotic hsp90, it will also be important to determine if 
hsp90 and pEpS share any functional relationships. Finally, 
because defects in the control of terminal differentiation is 
associated with the process of carcinogenesis (24, 42), can- 
cer cells need to be studied to determine the extent of aber- 
rant pep characteristics. For example, studies are now justi- 
fied to determine if alterations in the biosynthesis and/or 
structure of peps  in cancer cells  might contribute to ab- 
normalities in  their  growth and differentiation character- 
istics. 
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